New research could rescue failed immunotherapies for treating solid tumors
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon
Read more
New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon
Read moreSevere coronavirus disease 2019 (COVID-19) is associated with the development of acute respiratory distress syndrome (ARDS), characterized by exacerbated inflammation
Read moreA brief report by researchers at the University of Virginia, USA, proposes using an antibody-based treatment with a plug-and-play strategy
Read moreCoronaviruses are a large family of viruses that can infect both animals and humans. First identified in the 1960s, the
Read moreFrequently occurring chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and psoriasis have different causes such as genetic
Read moreThe currently approved mRNA vaccines from Moderna and Pfizer-BioNTech help create neutralizing antibodies against the severe acute respiratory syndrome (SARS-CoV-2)
Read moreA team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L.
Read moreThe immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus
Read moreGlioblastoma is among the most aggressive and devastating of cancers. While rare compared with other cancers, it's the most common
Read moreResearchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may
Read more